Breaking News Bar

Business News and Information

Recent Quotes
My Watchlist
Indicators
Local Stocks
The Daily Herald Market Index
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Nevro Corp (NY: NVRO )

175.96 USD -4.46 (-2.47%)
Official Closing Price Updated: 6:59 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Nevro Corp

< Previous 1 2 3 4 5 6 7 8 9 Next >
Clinical Data Presented at 2021 North American Neuromodulation Society (NANS) Virtual Meeting Reinforce Significant Benefits of Nevro's HF10® Therapy
PDN Randomized Trial Demonstrates Significantly Improved and Sustained Outcomes 
From PR Newswire
Nevro to Highlight New Clinical Evidence at the 2021 North American Neuromodulation Society (NANS) Virtual Meeting
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced a series of data presentations... 
From PR Newswire
Nevro Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2020 Revenue
Fourth Quarter 2020 Revenue of Approximately $109.7 Million 
From PR Newswire
Nevro Announces FDA Submission for HF10® Therapy in Patients with Painful Diabetic Neuropathy
SENZA-PDN Study is Largest Prospective, Multicenter, Randomized Clinical Trial of Spinal Cord Stimulation Conducted to Date 
From PR Newswire
Nevro to Host Virtual Investor Briefing at 2021 North American Neuromodulation Society (NANS) Virtual Conference
Friday, January 15, 2021, at 4:00 pm Pacific Time / 6:00 pm Central Time 
From PR Newswire
Nevro to Present at 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's... 
From PR Newswire
Boston Scientific Announces Stipulation Of Dismissal Of Nevro Corporation's Patent Infringement Case In California
Boston Scientific Corporation (NYSE: BSX) today announced that a stipulation of dismissal has been filed in the Nevro Corporation (NYSE: NVRO) patent infringement case against Boston Scientific in the... 
From PR Newswire
Nevro Announces Agreement to Conclude Its Patent Lawsuit in the Northern District of California Against Boston Scientific
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that, in its patent litigation... 
From PR Newswire
N&#275;sos Unveils First-of-its-Kind Wireless Earbud for the Treatment of Rheumatoid Arthritis
From WebWire
Nevro Announces Director Appointment
Industry Veteran Sue Siegel Joins the Board 
From PR Newswire
Nevro Appoints Julie D. Dewey as Vice President, Investor Relations and Corporate Communications
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that Julie Dewey has joined the... 
From PR Newswire
­Nevro to Participate in Citi Bank Head Shoulders Knees and Toes Conference Call Series on November 30th
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's... 
From PR Newswire
Nevro Announces Abstract Presentations for PDN and NSRBP Trials Have Been Accepted for the Late Breaking Trials Plenary Session at NANS 2021 Conference
Company to Host Investor Briefing to Review Latest Developments 
From PR Newswire
Nevro Announces Third Quarter 2020 Financial Results
- Worldwide revenues increase 8% 
From PR Newswire
Electrotherapy: Medical Company Medical Company Leaders MedTronic PLC (NYSE: MDT), Electromedical Technologies, Inc. (OTCQB: EMED) And Abbott Laboratories (NYSE: ABT) Offer Solutions for Chronic Pain
Tags Google News iCN Internal Distribution Financial Content
From iCrowdNewswire
Nevro to Report Third Quarter 2020 Financial Results
Company to Host Conference Call on Thursday, November 5, 2020 at 1:30 p.m. PT / 4:30 p.m. ET 
From PR Newswire
Nevro Initiates Plan for Manufacturing Operations in Costa Rica to Support Future Growth
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it will establish global... 
From PR Newswire
Nevro to Present at Upcoming Conferences
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's... 
From PR Newswire
Nevro to Present at Canaccord Genuity 40th Annual Virtual Growth Conference
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's... 
From PR Newswire
Nevro Announces Second Quarter 2020 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its financial results for the second... 
From PR Newswire
­Nevro to Report Second Quarter 2020 Financial Results
Company to Host Conference Call on Wednesday, August 5, 2020 at 1:30 p.m. PT / 4:30 p.m. ET 
From PR Newswire
Nevro Appoints Finance Executive Roderick MacLeod as Chief Financial Officer
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the appointment of Roderick ("Rod")... 
From PR Newswire
Nevro Announces CE Mark Approval of Senza® Omnia™ Spinal Cord Stimulation System to Treat Chronic Pain
- Next-generation system designed to provide physicians maximum versatility to manage chronic pain 
From PR Newswire
Nevro Reports First Quarter 2020 Financial Results
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced its financial results for the first... 
From PR Newswire
Nevro To Participate in Upcoming May Conferences
Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that Nevro Chairman, CEO and... 
From PR Newswire
Nevro to Report First Quarter 2020 Financial Results
Company to Host Conference Call on Tuesday, May 5, 2020 at 1:30 p.m. PT / 4:30 p.m. ET 
From PR Newswire
Nevro Announces Federal Circuit Rules in its Favor and Upholds the Validity of Nevro's Patent Claims In Its Litigation Against Boston Scientific
District Court's invalidity rulings were reversed by Appellate Court in a unanimous opinion. Nevro reaffirms confidence in its ability to maintain exclusivity of high frequency spinal cord... 
From PR Newswire
Nevro Announces the Full Exercise of the Underwriter's Option to Purchase Additional Common Stock and the Underwriter's Over-allotment Option to Purchase Additional Convertible Senior Notes
Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the underwriter of... 
From PR Newswire
Nevro Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes
Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the pricing of concurrent... 
From PR Newswire
Nevro Announces Proposed Public Offering of Common Stock and Convertible Senior Notes
Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has commenced a... 
From PR Newswire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
bottom clear
Search DailyHerald.com for articles
More ways to search Daily Herald
Obituaries
Search DailyHerald.com obituaries. » Daily Herald newspaper archive
Find archived newspaper articles back to 1901. »
Digital Subscriptions
Activate Subscriber Access Purchase a Digital Subscription
Home Delivery
Start a New Subscription Manage Account